Microfabricated Implantable Flowmeter for CSF Shunts Phase II

Information

  • Research Project
  • 8486498
  • ApplicationId
    8486498
  • Core Project Number
    R44NS056628
  • Full Project Number
    6R44NS056628-04
  • Serial Number
    056628
  • FOA Number
    PA-09-206
  • Sub Project Id
  • Project Start Date
    7/1/2006 - 18 years ago
  • Project End Date
    5/31/2015 - 9 years ago
  • Program Officer Name
    FERTIG, STEPHANIE
  • Budget Start Date
    6/1/2013 - 11 years ago
  • Budget End Date
    5/31/2015 - 9 years ago
  • Fiscal Year
    2013
  • Support Year
    04
  • Suffix
  • Award Notice Date
    8/8/2013 - 11 years ago
Organizations

Microfabricated Implantable Flowmeter for CSF Shunts Phase II

DESCRIPTION (provided by applicant): An implantable wireless flow sensor system has been under development that would enable measurement of the flow of cerebrospinal fluid (CSF) through the ventriculoperitoneal (VP) shunt, currently used to treat hydrocephalus patients. CSF flow is a key indicator of shunt function, and there is currently no way to measure it in situ, resulting in the absence of clinical methods to directly assess shunt function or to predict its failure. Using MEMS microfabrication methods, the proposed flow sensor will be manufactured at a size small enough to be integrable with implanted VP shunts. The key elements in the flow meter are capacitive structures that change properties with change in CSF flow. Electromagnetic coupling between the internal passive circuitry and an external handheld circuit allows implantation of the flow sensor without the need for implanted batteries or transcutaneous wires. The proposed Phase II project will build on the encouraging results of Phase I, which demonstrated the wireless interrogation of proof-of-concept MEMS sensors and the presence of a readily measurable relationship of flow to the resonance of the sensor. In Phase II, fully-function flow-sensing MEMS chips will be manufactured, as well as a revised handheld unit that will display and output flow, based on the known relationship between flow rate and resonance. In vitro testing will establish calibration for the sensor implants, and will demonstrate measurement accuracy over the full physiological range of CSF flow, over long periods of time, and with appropriate phantom models. In parallel, a chronic sheep hydrocephalus model will be in preparation, along with implementation of appropriate packaging, biocompatibility, and sterilizability into the sensor implant prototypes, as well as consideration of MR compatibility. Performance of an animal test protocol shall evaluate the sensor in regard to (1) sensitivity and specificity with regard to detection of flow obstruction, (2) CSF flow measurement accuracy, and (3) effect on shunt patency.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R44
  • Administering IC
    NS
  • Application Type
    6
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    962471
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    NINDS:962471\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    VIVONICS, INC.
  • Organization Department
  • Organization DUNS
    078513593
  • Organization City
    SUDBURY
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    017761142
  • Organization District
    UNITED STATES